Journal
STEM CELLS
Volume 24, Issue 4, Pages 1121-1127Publisher
WILEY
DOI: 10.1634/stemcells.2005-0463
Keywords
adult bone marrow stem cells; label; bromodeoxyuridine; thymidine analog; control; transplantation; neural differentiation; in vivo tracking
Ask authors/readers for more resources
Thymidine analogs, including bromodeoxyuridine, chlorode-oxytiridine, iododeoxyuridine, and tritiated thymidine, label dividing cells by incorporating into DNA during S phase of cell division and are widely employed to identify cells transplanted into the central nervous system. However, the potential for transfer of thymidine analogs from grafted cells to dividing host cells has not been thoroughly tested. We here demonstrate that graft-derived thymidine analogs can become incorporated into host neural precursors and glia. Large numbers of labeled neurons and glia were found 3-12 weeks after transplantation of thymidine analog-labeled live stem cells, suggesting differentiation of grafted cells. Remarkably, however, similar results were obtained after transplantation of dead cells or labeled fibroblasts. Our findings reveal for the first time that thymidine analog labeling may not be a reliable means of identifying transplanted cells, particularly in highly proliferative environments such as the developing, neurogenic, or injured brain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available